↓ Skip to main content

Dove Medical Press

Buprenorphine/samidorphan combination for the adjunctive treatment of major depressive disorder: results of a phase III clinical trial (FORWARD-3)

Overview of attention for article published in Neuropsychiatric Disease and Treatment, April 2019
Altmetric Badge

Mentioned by

facebook
1 Facebook page

Citations

dimensions_citation
23 Dimensions

Readers on

mendeley
57 Mendeley
Title
Buprenorphine/samidorphan combination for the adjunctive treatment of major depressive disorder: results of a phase III clinical trial (FORWARD-3)
Published in
Neuropsychiatric Disease and Treatment, April 2019
DOI 10.2147/ndt.s199245
Pubmed ID
Authors

John M Zajecka, Arielle D Stanford, Asli Memisoglu, William F Martin, Sanjeev Pathak

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 57 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 57 100%

Demographic breakdown

Readers by professional status Count As %
Student > Doctoral Student 8 14%
Student > Bachelor 8 14%
Researcher 7 12%
Student > Ph. D. Student 5 9%
Other 4 7%
Other 6 11%
Unknown 19 33%
Readers by discipline Count As %
Medicine and Dentistry 12 21%
Psychology 4 7%
Nursing and Health Professions 3 5%
Pharmacology, Toxicology and Pharmaceutical Science 3 5%
Mathematics 3 5%
Other 10 18%
Unknown 22 39%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 April 2019.
All research outputs
#22,767,715
of 25,385,509 outputs
Outputs from Neuropsychiatric Disease and Treatment
#2,583
of 3,131 outputs
Outputs of similar age
#318,222
of 364,342 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#55
of 70 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,131 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 364,342 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 70 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.